Does GEMTUZUMAB OZOGAMICIN Cause Hepatic failure? 25 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Hepatic failure have been filed in association with GEMTUZUMAB OZOGAMICIN (Mylotarg). This represents 1.4% of all adverse event reports for GEMTUZUMAB OZOGAMICIN.
25
Reports of Hepatic failure with GEMTUZUMAB OZOGAMICIN
1.4%
of all GEMTUZUMAB OZOGAMICIN reports
14
Deaths
8
Hospitalizations
How Dangerous Is Hepatic failure From GEMTUZUMAB OZOGAMICIN?
Of the 25 reports, 14 (56.0%) resulted in death, 8 (32.0%) required hospitalization, and 12 (48.0%) were considered life-threatening.
Is Hepatic failure Listed in the Official Label?
Yes, Hepatic failure is listed as a known adverse reaction in the official FDA drug label for GEMTUZUMAB OZOGAMICIN.
What Other Side Effects Does GEMTUZUMAB OZOGAMICIN Cause?
Febrile neutropenia (412)
Pyrexia (138)
Sepsis (122)
Thrombocytopenia (117)
Venoocclusive liver disease (117)
Off label use (88)
Drug ineffective (87)
Death (81)
Bone marrow failure (80)
Neutropenia (68)
What Other Drugs Cause Hepatic failure?
ACETAMINOPHEN (1,392)
RIBAVIRIN (888)
CYCLOPHOSPHAMIDE (629)
METHOTREXATE (598)
BEVACIZUMAB (558)
SOFOSBUVIR (525)
RITUXIMAB (513)
VINCRISTINE (468)
DOXORUBICIN (462)
PREDNISOLONE (425)
Which GEMTUZUMAB OZOGAMICIN Alternatives Have Lower Hepatic failure Risk?
GEMTUZUMAB OZOGAMICIN vs GEMZAR
GEMTUZUMAB OZOGAMICIN vs GENTAMICIN
GEMTUZUMAB OZOGAMICIN vs GEODON
GEMTUZUMAB OZOGAMICIN vs GILENYA
GEMTUZUMAB OZOGAMICIN vs GILOTRIF